$Novo Nordisk AS(NVO.US) Just look at the key information. 1. The Parkinson's therapy was acquired. 2. The stock grant. These two pieces of information seem unrelated and insignificant. Let's talk about the first one: Would a normal and healthy company rely on being acquired to make its books look good? The second one: Granting stock to test market reaction? And a grant doesn't even count as a reduction in holdings?
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
